Muscle Ring Finger 1, but not Muscle Ring Finger 2, Regulates Cardiac Hypertrophy In Vivo
暂无分享,去创建一个
Cam Patterson | Monte S. Willis | Da-Zhi Wang | C. Patterson | D. Glass | Luge Li | M. Willis | Da-Zhi Wang | C. Ike | Luge Li | David J. Glass | Christopher Ike
[1] Thomas Sejersen,et al. The Kinase Domain of Titin Controls Muscle Gene Expression and Protein Turnover , 2005, Science.
[2] Masahiko Hoshijima,et al. Mechanical stress-strain sensors embedded in cardiac cytoskeleton: Z disk, titin, and associated structures. , 2006, American journal of physiology. Heart and circulatory physiology.
[3] Claudia E Korcarz,et al. Use of echocardiography for the phenotypic assessment of genetically altered mice. , 2003, Physiological genomics.
[4] Holly McDonough,et al. Muscle ring finger protein-1 inhibits PKCε activation and prevents cardiomyocyte hypertrophy , 2004, The Journal of cell biology.
[5] L. Michael,et al. CHIP, a cochaperone/ubiquitin ligase that regulates protein quality control, is required for maximal cardioprotection after myocardial infarction in mice. , 2005, American journal of physiology. Heart and circulatory physiology.
[6] D J Glass,et al. Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy , 2001, Science.
[7] E. Abel,et al. Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload. , 2003, American journal of physiology. Heart and circulatory physiology.
[8] Da-Zhi Wang,et al. Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex. , 2004, The Journal of clinical investigation.
[9] Cam Patterson,et al. Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I , 2004, Proceedings of the National Academy of Sciences of the United States of America.